Rockefeller Capital Management’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.23M Buy
2025
Q4
$18K Buy
2025
Q3
$6.72K Buy